NASDAQ : AEMD
Aethlon Medical, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 5.44 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.87M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Details
| Name | Aethlon Medical, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 9 |
| Founded | 1984 |
| Ceo | James Frakes |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| Isin | US00808Y7031 |
| Cusip | 00808Y703 |
| Cik | 0000882291 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| James B. Frakes M.B.A. | Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary and Director |
| Dr. Steven P. LaRosa M.D. | Chief Medical Officer |
| Michele Bombardiere | Vice President and Controller |
Contact
| Address | 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121, United States |
| Phone | 619 941 0360 |
| Website | https://www.aethlonmedical.com |